The Enterprise Value as of June 2026 (TTM) for Opus Genetics, Inc. (IRD) is 294.81M

According to Opus Genetics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 294.81M. This represents a change of -77.50% compared to the average of 1.31B of the last 4 quarters.

Opus Genetics, Inc. (IRD) Historical Enterprise Value (quarterly & annually)

How has IRD Enterprise Value performed in the past?

The mean historical Enterprise Value of Opus Genetics, Inc. over the last ten years is 166.50M. The current 294.81M Enterprise Value has changed 17.61% with respect to the historical average. Over the past ten years (40 quarters), IRD's Enterprise Value was at its highest in in the March 2026 quarter at 3.92B. The Enterprise Value was at its lowest in in the December 2023 quarter at -22742476.85.

Opus Genetics, Inc. (IRD) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Opus Genetics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Opus Genetics, Inc. (IRD) Average Enterprise Value

How has IRD Enterprise Value performed in the past?

The current Enterprise Value of Opus Genetics, Inc. (IRD) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Opus Genetics, Inc. (IRD) Enterprise Value vs. Peers

How is IRD’s Enterprise Value compared to its peers?

Opus Genetics, Inc.’s Enterprise Value is greater than Acumen Pharmaceuticals, Inc. (105.89M), greater than Seer, Inc. (70.28M), less than Agenus Inc. (406.89M), greater than Inovio Pharmaceuticals, Inc. (41.37M), greater than VistaGen Therapeutics, Inc. (-27060355.00), greater than TuHURA Biosciences, Inc. (141.90M), greater than Alector, Inc. (127.45M), greater than Cognition Therapeutics, Inc. (58.37M), greater than Instil Bio, Inc. (48.69M), greater than Seres Therapeutics, Inc. (105.86M),

Build a custom stock screener for Opus Genetics, Inc. (IRD) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Opus Genetics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Opus Genetics, Inc. (IRD) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Opus Genetics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.